The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.
ISICEM – International Symposium on Intensive Care and Emergency Medicine in Brussels – March 21th to 24th, 2023
During the 42nd ISICEM the concept and areas of use of the CARL Therapy for the treatment of resuscitation patients after sudden cardiac arrest will be presented to a European professional audience.
Experts of the CARL Academy will explain the associated and especially developed CARL Technology in a hands-on workshop on Thursday, March 23rd, from 9 a.m. to 10 a.m., titled “Hands-on CARL – Set up and priming in a resuscitation scenario.”